SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

TRANSGENE BIOTEK

BSE: 526139 29 Sep 2025
Healthcare
₹ 4.15
Transgene Biotek Ltd. specializes in Healthcare Service Provider within the Healthcare sector.

TRANSGENE BIOTEK - Share Price & Details

Market Cap
₹32.2
High /Low
10.8 / 3.22
Stock P/E
NA
Book Value
₹-1.0
Dividend Yield
0.0
ROCE
-6.11
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-137.0
Debt
14.5
CMP / FCF
-193.0
Debt to equity
₹NA
NP Ann
-0.68
High price all time
322.0
Piotroski score
₹4.0
Graham Number
NA
No. Eq. Shares
7.58
Net CF
₹0.28
Net profit
-0.68
Price to book value
NA
Interest Coverage
₹-1.79
Low price all time
1.55
Industry PE
50.6
Reserves
₹-83.3
Free Cash Flow
₹-0.50

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
TRANSGENE BIOTEK LTD.NANANANA32.2
KK Shah Hospitals LimitedNANANANA30.3
Shree Ganesh Biotech (India) LNANANANA29.963.6

Peer Comparison Chart


About TRANSGENE BIOTEK

Transgene Biotek Ltd., with Security Code 526139, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

(15 Sep 2025)
The top mid-cap gainers were Piramal Enterprises Ltd, Tata Communications Ltd, NHPC Ltd and Tube Investments of India Ltd.
Read more →

Transgene Biotek reports consolidated net loss of Rs 0.27 crore in the March 2024 quarter

(13 Sep 2025)
Net Loss of Transgene Biotek reported to Rs 0.27 crore in the quarter ended March 2024 as against net loss of Rs 1.47 crore during the previous quarte...
Read more →

Transgene Biotek reports consolidated net loss of Rs 0.43 crore in the June 2025 quarter

(07 Aug 2025)
Net loss of Transgene Biotek reported to Rs 0.43 crore in the quarter ended June 2025 as against net profit of Rs 0.20 crore during the previous quarter...
Read more →

Aegis Vopak Terminals consolidated net profit rises 85.10% in the June 2025 quarter

(07 Aug 2025)
Net profit of Aegis Vopak Terminals rose 85.10% to Rs 47.72 crore in the quarter ended June 2025 as against Rs 25.78 crore during the...
Read more →

Double Dhamaka! 1:1 bonus share & 1:10 stock split announced: Multibagger hydraulics manufacturing stock locked in lower circuit!

(06 Aug 2025)
The stock has given multibagger returns of over 150 per cent from its 52-week low is Rs 1,170 per share. On Wednesday, shares of Bemco...
Read more →

EUR/USD gains for third session, firm retail sales data from Eurozone boosts sentiments

(05 Aug 2025)
Euro is gaining steadily this week as supportive equities and steady economic outlook are boosting the single currency. EUR/USD pair is...
Read more →